Alambic Investment Management, L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$310,000
-92.6%
18,355
-91.5%
0.08%
-85.5%
Q1 2018$4,210,000
+266.1%
214,887
+278.5%
0.59%
+324.6%
Q4 2017$1,150,000
+55.6%
56,773
+33.4%
0.14%
+70.4%
Q3 2017$739,000
+84.3%
42,573
+36.1%
0.08%
+65.3%
Q2 2017$401,000
+2.8%
31,273
+4.0%
0.05%
+2.1%
Q1 2017$390,000
+124.1%
30,073
+71.1%
0.05%
+54.8%
Q4 2016$174,000
-17.9%
17,5730.0%0.03%
-38.0%
Q3 2016$212,000
+29.3%
17,573
-7.4%
0.05%
+22.0%
Q2 2016$164,000
-65.0%
18,973
-61.7%
0.04%
-73.0%
Q1 2016$469,000
-23.5%
49,573
+40.0%
0.15%
-58.8%
Q4 2015$613,00035,4000.37%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders